|
ST7L expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.113400E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.349230E-01 |
| Normal-vs-Stage2 |
4.053700E-02 |
| Normal-vs-Stage3 |
5.322000E-01 |
| Normal-vs-Stage4 |
2.101700E-02 |
| Stage1-vs-Stage2 |
3.484400E-01 |
| Stage1-vs-Stage3 |
4.269800E-01 |
| Stage1-vs-Stage4 |
6.410400E-02 |
| Stage2-vs-Stage3 |
3.635000E-01 |
| Stage2-vs-Stage4 |
5.759200E-01 |
| Stage3-vs-Stage4 |
3.186800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.118600E-01 |
| Normal-vs-AfricanAmerican |
3.577600E-02 |
| Normal-vs-Asian |
7.594300E-02 |
| Caucasian-vs-AfricanAmerican |
1.906960E-01 |
| Caucasian-vs-Asian |
8.524300E-02 |
| AfricanAmerican-vs-Asian |
5.156200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.900500E-03 |
| Normal-vs-Female |
3.169400E-01 |
| Male-vs-Female |
9.250400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.982800E-01 |
| Normal-vs-Extreme_Weight |
1.741180E-01 |
| Normal-vs-Obese |
5.264000E-02 |
| Normal-vs-Extreme_Obese |
2.618200E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.347800E-01 |
| Normal_Weight-vs-Obese |
2.967400E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.298600E-01 |
| Extreme_Weight-vs-Obese |
7.109000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.347600E-01 |
| Obese-vs-Extreme_Obese |
9.066600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.294500E-02 |
| Normal-vs-Age(41-60Yrs) |
6.913800E-01 |
| Normal-vs-Age(61-80Yrs) |
7.311000E-01 |
| Normal-vs-Age(81-100Yrs) |
2.345000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.029500E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.821200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.515000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.245200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.666800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.161200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.928400E-02 |
| Normal-VS-Type2 PRCC |
6.687400E-01 |
| Normal-VS-KIRP CIMP |
1.182630E-01 |
| Normal-VS-Unclassified PRCC |
9.863200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.316400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
8.513000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.731200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.014000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.152000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.231600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.537710E-02 |
| Normal-vs-N1 |
5.211000E-01 |
| Normal-vs-N2 |
1.455980E-01 |
| N0-vs-N1 |
3.709400E-01 |
| N0-vs-N2 |
7.880000E-01 |
| N1-vs-N2 |
3.434800E-01 |
|
|
